SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ebert, T
Right arrow Articles by Shoenfeld, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebert, T
Right arrow Articles by Shoenfeld, Y
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?

T Ebert

Beer Yaakov Mental Health Center, Tel Aviv University, Tel-Aviv, Israel, Incumbent of the Laura Schwartz-Kipp Chair for Autoimmunity, Tel-Aviv University, Tel-Aviv, Israel

J Chapman

Department of Neurology, Tel Aviv University, Tel-Aviv, Israel, Incumbent of the Laura Schwartz-Kipp Chair for Autoimmunity, Tel-Aviv University, Tel-Aviv, Israel

Y Shoenfeld

Department of Medicine B and Center for Autoimmune Disease, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel, Incumbent of the Laura Schwartz-Kipp Chair for Autoimmunity, Tel-Aviv University, Tel-Aviv, Israel, shoenfel{at}post.tau.ac.il

Systemic lupus erythematosus (SLE) is an autoimmune disease that may involve the central nervous system (CNS) resulting in neuropsychiatric manifestations. The associated psychiatric disorders include depression, psychosis, mood disorders, anxiety, cognitive dysfunction, and delirium/encephalopathy. Several autoantibodies may play a role in the pathogenesis of psychiatric complications of SLE, particularly antibodies against ribosomal P-proteins (anti-P) and possibly antibodies against endothelial cells (AECA). The reported prevalence of anti-P is highly variable in SLE patients and is dependent on different ethnic backgrounds, sensitivity and specificity of the assays employed for autoantibody detection, and the time at which sera were analysed in relation to the clinical event. Controversial data exist on the association of anti-P with psychiatric manifestations of SLE. These autoantibodies have been suggested to be specific markers of the psychiatric manifestations of SLE, particularly of the psychosis and depression, and the antibody level varied with the clinical activity of the disease. Some studies have confirmed the hypothesis of an association of anti-P antibodies with psychiatric manifestations of neuropsychiatric SLE (NPSLE) while others have disputed this relationship. This review summarizes the recent studies about relationship between anti-P antibodies and psychiatric manifestation of SLE.

Key Words: anti-ribosomal P-protein • psychiatric manifestations • systemic lupus erythematosus

Lupus, Vol. 14, No. 8, 571-575 (2005)
DOI: 10.1191/0961203305lu2150rr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. Haddouk, S. Marzouk, M. Jallouli, H. Fourati, M. Frigui, Y. B. H. Hmida, F. Koubaa, W. Sellami, S. Baklouti, J. Hachicha, et al.
Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus
Rheumatology, August 1, 2009; 48(8): 953 - 957.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Matus, P. V. Burgos, M. Bravo-Zehnder, R. Kraft, O. H. Porras, P. Farias, L. F. Barros, F. Torrealba, L. Massardo, S. Jacobelli, et al.
Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis
J. Exp. Med., December 24, 2007; 204(13): 3221 - 3234.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Kowal, L. A. DeGiorgio, J. Y. Lee, M. A. Edgar, P. T. Huerta, B. T. Volpe, and B. Diamond
From the Cover: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment
PNAS, December 26, 2006; 103(52): 19854 - 19859.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
H-H Yu, J-H Lee, L-C Wang, Y-H Yang, and B-L Chiang
Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study
Lupus, October 1, 2006; 15(10): 651 - 657.
[Abstract] [PDF]



Advertisement